Short-term effects of weight loss on the cardiovascular risk factors in morbidly obese patients

被引:32
作者
Busetto, L [1 ]
Sergi, G [1 ]
Enzi, G [1 ]
Segato, G [1 ]
De Marchi, F [1 ]
Foletto, M [1 ]
De Luca, M [1 ]
Pigozzo, S [1 ]
Favretti, F [1 ]
机构
[1] Univ Padua, Dept Med & Surg Sci, Obes Unit, Padua, Italy
来源
OBESITY RESEARCH | 2004年 / 12卷 / 08期
关键词
cardiovascular risk; weight loss; morbid obesity; gastric banding;
D O I
10.1038/oby.2004.159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze the short-term effects of weight loss on the cardiovascular risk factors in morbidly obese patients. Research Methods and Procedures: Five metabolic cardiovascular risk factors (blood glucose, blood pressure, total cholesterol, high-density lipoprotein (HDL)-cholesterol, and triglycerides) were determined before and 15.3 +/- 2.1 months after laparoscopic gastric banding in 650 morbidly obese patients. Global cardiovascular risk was calculated according to the Prospective Cardiovascular Munster (PROCAM) scoring system. Results: Mean weight loss was 22.7 +/- 20.4 kg. Normalization of the metabolic alteration was observed in 67.3% of patients with diabetes, 38.3% of patients with hypercholesterolemia, 72.5% of patients with low HDL-cholesterol, 72.3% of patients with hypertriglyceridemia, and 46.7% of patients with hypertension. PROCAM score fell from 31.4 +/- 11.6 to 28.0 +/- 12.0 points (p < 0.001). The modifications of total cholesterol and blood pressure were unrelated to percentage weight loss. Percentage weight loss was significantly related to the reductions of fasting blood glucose, triglyceride level, and the PROCAM score and to the increase of HDL-cholesterol concentrations observed after surgery. However, the strength of these four relationships was generally low. The variations of HDL-cholesterol concentrations and blood pressure levels were more influenced by actual energy balance than by the extent of weight loss. Discussion: Weight loss observed in the first 12 to 18 months after gastric banding was associated with a significant improvement of single cardiovascular risk factors and global risk. On the other hand, the extent of weight loss was poorly related to the magnitude of improvement in cardiovascular risk.
引用
收藏
页码:1256 / 1263
页数:8
相关论文
共 21 条
[1]  
[Anonymous], 1998, CLIN GUID ID EV TREA
[2]   Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[3]   Outcome predictors in morbidly obese recipients of an adjustable gastric band [J].
Busetto, L ;
Segato, G ;
De Marchi, F ;
Foletto, M ;
De Luca, M ;
Caniato, D ;
Favretti, F ;
Lise, M ;
Enzi, G .
OBESITY SURGERY, 2002, 12 (01) :83-92
[4]   Variation in lipid levels in morbidly obese patients operated with the LAP-BAND® adjustable gastric banding system:: Effects of different levels of weight loss [J].
Busetto, L ;
Pisent, C ;
Rinaldi, D ;
Longhin, PL ;
Segato, G ;
De Marchi, F ;
Foletto, M ;
Favretti, F ;
Lise, M ;
Enzi, G .
OBESITY SURGERY, 2000, 10 (06) :569-577
[5]   The influence of a new timing strategy of band adjustment on the vomiting frequency and the food consumption of obese women operated with laparoscopic adjustable silicone gastric banding (LAP-BAND) [J].
Busetto, L ;
Pisent, C ;
Segato, G ;
De marchi, F ;
Favretti, F ;
Lise, M ;
Enzi, G .
OBESITY SURGERY, 1997, 7 (06) :505-512
[6]   Laparoscopic adjustable silicone gastric banding (LAP-BAND(R)): How to avoid complications [J].
Favretti, F ;
Cadiere, GB ;
Segato, G ;
Himpens, J ;
Busetto, L ;
DeMarchi, F ;
Vertruyen, M ;
Enzi, G ;
DeLuca, M ;
Lise, M .
OBESITY SURGERY, 1997, 7 (04) :352-358
[7]   Laparoscopic banding:: Selection and technique in 830 patients [J].
Favretti, F ;
Cadière, GB ;
Segato, G ;
Himpens, J ;
De Luca, M ;
Busetto, L ;
De Marchi, F ;
Foletto, M ;
Caniato, D ;
Lise, M ;
Enzi, G .
OBESITY SURGERY, 2002, 12 (03) :385-390
[8]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[9]  
GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
[10]   Role of orlistat in the treatment of obese patients with type 2 diabetes - A 1-year randomized double-blind study [J].
Hollander, PA ;
Elbein, SC ;
Hirsch, IB ;
Kelley, D ;
McGill, J ;
Taylor, T ;
Weiss, SR ;
Crockett, SE ;
Kaplan, RA ;
Comstock, J ;
Lucas, CP ;
Lodewick, PA ;
Canovatchel, W ;
Chung, J ;
Hauptman, J .
DIABETES CARE, 1998, 21 (08) :1288-1294